Form 8-K · Current report
Zebra Technologies 8-K, filed Aug 4, 2026
- Filed
- CIK
- 0000877212
- Accession no.
- 0001628280-26-052158
Summary
Zebra Technologies reported second-quarter 2026 net sales of $1,557 million, up 20.4% year over year, net income of $233 million, or $4.85 per diluted share, and non-GAAP diluted EPS of $6.35, and raised its full-year outlook. The company said it expects full-year sales growth of 14%-16% and non-GAAP diluted EPS of $20.75-$21.25, with CEO Bill Burns citing broad-based demand and CFO Nathan Winters pointing to share repurchases and balance-sheet flexibility.
Key points
- Second-quarter net sales rose 20.4% year over year to $1,557 million, with organic net sales growth of 9.2%.
- Net income was $233 million, or $4.85 per diluted share, and non-GAAP diluted EPS was $6.35.
- Zebra recorded $73 million in IEEPA tariff recoveries, of which $14 million was received in the quarter.
- Full-year 2026 guidance was raised to 14%-16% sales growth, a 23.5%-24.0% adjusted EBITDA margin, and non-GAAP diluted EPS of $20.75-$21.25.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Conditions. The information contained in this Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. On August 4, 2026, we announced our results of operations and financial position as of and for the second quarter ended July 4, 2026. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.